Home/Filings/4/0001468308-26-000006
4//SEC Filing

Andrade Robert 4

Accession 0001468308-26-000006

CIK 0001211583other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:05 PM ET

Size

7.3 KB

Accession

0001468308-26-000006

Insider Transaction Report

Form 4
Period: 2026-01-15
Andrade Robert
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common shares

    [F1]
    2026-01-15$2.45/sh+10,000$24,500201,100 total
  • Exercise/Conversion

    Stock Options

    [F1]
    2026-01-15$2.45/sh10,000$24,500826,567 total
    Exercise: $2.45From: 2016-07-05Exp: 2026-07-05Options (10,000 underlying)
Footnotes (1)
  • [F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.
Signature
/s/ Robert Andrade|2026-01-15

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1
  • filerCIK 0001468308

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:05 PM ET
Size
7.3 KB